Impulses for the Healthcare System of Tomorrow
On 6 October 2026, the Medical Technology Cluster brought together scientists, stakeholders and industry representatives at the MedTech.Circle event at the PowerTower of Energie AG OÖ. LBI Trauma also presented current research approaches with the potential to open up new perspectives in regenerative medicine.
Extracellular Vesicles and Senolytics: New Approaches to Regenerative Medicine
During the InnoMatch session, LBI Trauma science communicator Conny Schneider had just two minutes to present the institute’s latest research approaches. Her pitch focused on extracellular vesicles and senolytics. Extracellular vesicles (EVs) are tiny structures released by cells that transport biological signals and offer promising opportunities for targeted therapeutic applications. As a specific research example, Schneider presented laminin-binding EVs, which David Hercher and his team are investigating for the targeted regeneration of peripheral nerves.
Another highlight was the potential of senolytics—substances that selectively target senescent cells, which have entered a state of permanent cell-cycle arrest. A striking example involving a mouse in which senolytic treatment reversed signs of ageing illustrated the new possibilities that research into cellular ageing could open up for biomedical science. The example stayed with attendees and became a running joke throughout the afternoon. Schneider emphasised, however, that the full therapeutic implications still require further scientific investigation.
Breaking Down Silos and Fostering Innovation
Beyond the scientific topics, collaboration between different areas of the healthcare system was also a key focus. During the World Café session on the “Patient Journey,” Schneider’s group discussed in particular the interface between intramural and extramural care. In the concluding Fishbowl discussion, Schneider addressed the lack of coordination between different parts of the healthcare system. These areas often operate in silos: communication and information exchange are not always sufficient, responsibilities sometimes remain unclear, and responsibility for patients and costs is shifted between sectors. Breaking down these structural barriers is a key challenge—and an important prerequisite for more efficient and better-coordinated healthcare.
Alongside overcoming siloed thinking, three further goals were highlighted as important guiding principles for the future of medical technology: greater prevention, more transparency and better collaboration.
The discussions at MedTech.Circle demonstrated the importance of closer links between basic research, technological development and clinical needs. For LBI Trauma, this kind of networking is essential to advancing innovative approaches in traumatology and tissue regeneration and to creating opportunities for new collaborations.